Powered by

Powered by Portfolio Grader

Regeneron Pharmaceuticals (REGN)

391.80 10.79 (2.68%) 17:45 EDT
REGN Stock Quote Delayed 15 Minutes
  • REGN Stock Chart

  • Historical REGN Prices

 
Dividend & Yield:       N/A (N/A)
P/E:       31.75
Market Cap:       41.51B
EPS:       12.34
Volume:       552,500
Day's Range:       391.43 - 402.59
52wk Range:       281.89 - 442.00
Quotes delayed at least 20 mins.
Historical Data for REGN
Date Open High Low Volume Close Change %
03/22/19 401.48 402.59 391.42 552,575 391.80 -10.79   -2.68%
03/21/19 401.00 405.12 396.84 880,931 402.59 -2.91   -0.72%
03/20/19 407.79 409.68 402.82 479,457 405.50 -1.49   -0.37%
03/19/19 407.74 409.72 404.40 627,914 406.99 -0.61   -0.15%
03/18/19 410.00 413.76 404.84 542,488 407.60 -6.87   -1.66%
03/15/19 408.47 415.00 408.40 1,158,400 414.47 6.97   1.71%
03/14/19 409.89 412.36 406.34 925,241 407.50 -1.51   -0.37%
03/13/19 419.38 419.60 408.53 988,810 409.01 -8.61   -2.06%
03/12/19 413.56 421.80 411.19 839,728 417.62 5.57   1.35%
03/11/19 404.15 413.21 402.25 874,204 412.05 9.41   2.34%
03/08/19 407.51 407.51 399.58 1,091,700 402.64 -6.94   -1.69%
03/07/19 422.90 422.90 409.19 1,020,804 409.58 -14.11   -3.33%
03/06/19 436.93 438.02 421.30 812,303 423.69 -13.44   -3.07%
03/05/19 432.12 439.65 430.49 478,274 437.13 3.30   0.76%
03/04/19 441.18 442.00 428.36 769,285 433.83 -5.74   -1.31%
03/01/19 434.80 440.05 431.93 510,900 439.57 8.83   2.05%
02/28/19 430.19 434.35 428.62 513,900 430.74 -2.59   -0.60%
02/27/19 424.00 433.74 424.00 598,772 433.33 7.18   1.68%
02/26/19 418.57 428.06 415.83 611,107 426.15 5.77   1.37%
02/25/19 424.94 426.53 415.76 660,430 420.38 -2.14   -0.51%
02/22/19 418.21 423.64 416.00 386,600 422.52 3.90   0.93%
02/21/19 421.81 422.61 415.58 406,583 418.62 -3.89   -0.92%
02/20/19 420.00 423.40 417.08 411,138 422.51 1.91   0.45%
02/19/19 423.74 426.41 420.35 397,795 420.60 -3.37   -0.79%
02/15/19 417.97 424.39 415.72 700,000 423.97 9.00   2.17%
02/14/19 412.00 416.26 408.57 349,581 414.97 2.88   0.70%
02/13/19 415.98 421.66 411.51 349,323 412.09 -4.25   -1.02%
02/12/19 411.56 418.10 408.02 636,908 416.34 7.83   1.92%
02/11/19 409.37 413.35 403.00 550,289 408.51 1.65   0.41%
02/08/19 405.44 408.00 399.29 692,100 406.86 0.40   0.10%
02/07/19 408.29 414.22 404.27 737,188 406.46 -0.10   -0.02%
02/06/19 428.90 429.90 406.40 1,329,517 406.56 -14.48   -3.44%
02/05/19 426.11 427.50 419.63 600,490 421.04 -4.36   -1.02%
02/04/19 428.92 429.06 422.49 473,745 425.40 -4.75   -1.10%
02/01/19 428.52 431.32 425.32 702,500 430.15 0.88   0.20%
01/31/19 419.68 430.58 419.45 1,441,779 429.27 9.36   2.23%
01/30/19 416.35 420.44 412.63 867,844 419.91 2.76   0.66%
01/29/19 415.72 418.51 413.00 708,222 417.15 3.20   0.77%
01/28/19 415.11 416.49 408.81 761,029 413.95 -4.34   -1.04%
01/25/19 410.85 418.95 406.10 692,400 418.29 10.36   2.54%
01/24/19 401.80 408.88 399.16 655,037 407.93 6.72   1.67%
01/23/19 404.92 406.79 393.17 913,955 401.21 -3.54   -0.87%
01/22/19 415.77 421.99 404.00 899,711 404.75 -14.09   -3.36%
01/18/19 420.42 420.48 410.00 710,400 418.84 1.46   0.35%
01/17/19 402.72 420.29 402.72 859,341 417.38 12.84   3.17%
01/16/19 406.17 410.63 402.85 441,649 404.54 -0.48   -0.12%
01/15/19 401.42 405.16 399.63 471,934 405.02 4.29   1.07%
01/14/19 408.16 408.16 399.11 693,334 400.73 -7.90   -1.93%
01/11/19 405.65 412.29 403.55 757,900 408.63 0.57   0.14%
01/10/19 399.40 410.00 395.98 949,293 408.06 8.48   2.12%
01/09/19 398.02 401.46 395.61 612,490 399.58 2.32   0.58%
01/08/19 399.31 401.09 389.00 906,768 397.26 0.63   0.16%
01/07/19 397.34 400.80 393.94 959,369 396.63 -0.92   -0.23%
01/04/19 379.54 399.70 377.65 1,207,600 397.55 25.47   6.85%
01/03/19 373.66 385.94 371.58 736,431 372.08 -0.36   -0.10%
Regeneron Pharmaceuticals (REGN) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Regeneron Pharmaceuticals Stock Analysis

Rating: Buy

Total Grade: B

Analysis Breakdown

REGN Stock Grade: B
Fundamental Grade: B
Quantitative Grade: B
REGN Earnings
Earnings Growth: A
Earnings Momentum: F
Earnings Surprises: A
Analyst Earnings Revisions: B
REGN Financial Information
Sales Growth: B
Operating Margin Growth: A
Cash Flow: B
Return on Equity: A

Regeneron Pharmaceuticals Stock: Weekly View

This Week: B
Last Week: A
Two Weeks Ago: A
Get Full Report